MedPath
TGA Approval

OLAMLO HCT 40/5/25 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/5/25 mg film-coated tablet blister pack (312005)

312005

OLAMLO HCT 40/5/25 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/5/25 mg film-coated tablet blister pack

Accord Healthcare Pty Ltd

November 21, 2019

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/4a781407a821229ce6a43df36ef7a530.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/627f347c784d62e06a0061eae5cd804e.pdf

Active Ingredients

amlodipine besilate

hydrochlorothiazide

olmesartan medoxomil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

OLAMLO HCT 40/5/25 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/5/25 mg film-coated tablet blister pack (312005) - TGA 批准文号 | MedPath